Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 18, 2019

SELL
$11.63 - $32.67 $1,860 - $5,227
-160 Closed
0 $0
Q3 2018

Nov 01, 2018

SELL
$29.37 - $49.48 $2,349 - $3,958
-80 Reduced 33.33%
160 $5,000
Q2 2018

Aug 14, 2018

BUY
$42.06 - $62.4 $3,364 - $4,992
80 Added 50.0%
240 $11,000
Q1 2018

May 01, 2018

BUY
$50.12 - $67.72 $4,009 - $5,417
80 Added 100.0%
160 $8,000
Q4 2017

Feb 06, 2018

BUY
$57.69 - $84.58 $2,307 - $3,383
40 Added 100.0%
80 $5,000
Q3 2017

Nov 03, 2017

BUY
$67.17 - $84.81 $2,686 - $3,392
40
40 $3,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Alpha Omega Wealth Management LLC Portfolio

Follow Alpha Omega Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Omega Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Omega Wealth Management LLC with notifications on news.